Xevinapant | Interleukin Related interleukin-related.com

Product Name :
Xevinapant

Search keywords :
Xevinapant

drugId :
null

Target Vo:
Inhibitor of apoptosis protein 3

Target Vo Short Name :
IAP3

Moa_Name:
Inhibitor of apoptosis protein 3 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ascenta

Active Company_Name :
Debiopharm International Sa

Active Indication_Name:
Squamous Cell Carcinoma of Head and Neck

In Active Indication_Name:
Leukemia, Myeloid, Acute

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ki67 Rabbit mAb Autophagy
MCP1 Antibody In stock
TRAF6 Antibody: TRAF6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to TRAF6. It can be used for WB assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts